| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
AC50 |
138563.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Blood |
IC50 |
110.0 |
nM |
10.1021/jm900210d |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
10000.0 |
nM |
10.1021/jm900210d |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
10000.0 |
nM |
10.1021/jm900210d |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
10000.0 |
nM |
10.1021/jm900210d |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
10000.0 |
nM |
10.1021/jm900210d |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
10000.0 |
nM |
10.1021/jm900210d |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
3.2 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
7.54 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
PBMC |
IC50 |
77.0 |
nM |
10.1021/jm900210d |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4 |
IC50 |
74.0 |
nM |
10.1021/acs.jmedchem.9b02170 |
| Homo sapiens |
Phosphodiesterase 4 |
IC50 |
74.0 |
nM |
10.1021/jm900210d |
| Homo sapiens |
Phosphodiesterase 4 |
IC50 |
110.0 |
nM |
10.1021/acs.jmedchem.9b00518 |
| Homo sapiens |
Phosphodiesterase 4A |
Inhibition |
8.0 |
% |
10.1016/j.ejmech.2019.04.020 |
| Homo sapiens |
Phosphodiesterase 4A |
Inhibition |
57.0 |
% |
10.1016/j.ejmech.2019.04.020 |
| Homo sapiens |
Phosphodiesterase 4A |
Inhibition |
91.0 |
% |
10.1016/j.ejmech.2019.04.020 |
| Homo sapiens |
Phosphodiesterase 4B |
IC50 |
24.0 |
nM |
10.1021/acs.jmedchem.9b00193 |
| Homo sapiens |
Phosphodiesterase 4B |
IC50 |
27.0 |
nM |
10.1016/j.ejmech.2019.04.020 |
| Homo sapiens |
Phosphodiesterase 4B |
IC50 |
30.0 |
nM |
10.1021/acs.jmedchem.7b01751 |
| Homo sapiens |
Phosphodiesterase 4B |
IC50 |
74.0 |
nM |
10.1016/j.bmc.2016.09.011 |
| Homo sapiens |
Phosphodiesterase 4B |
Imax |
100.0 |
% |
10.1021/acs.jmedchem.9b00193 |
| Homo sapiens |
Phosphodiesterase 4B |
Inhibition |
nan |
% |
10.1016/j.bmc.2016.09.011 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
2.7 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
IC50 |
33.0 |
nM |
10.1016/j.ejmech.2019.04.020 |
| Homo sapiens |
Phosphodiesterase 4D |
IC50 |
35.0 |
nM |
10.1021/acs.jmedchem.9b00193 |
| Homo sapiens |
Phosphodiesterase 4D |
IC50 |
47.6 |
nM |
10.1021/acs.jnatprod.9b01269 |
| Homo sapiens |
Phosphodiesterase 4D |
IC50 |
74.0 |
nM |
10.1021/acs.jmedchem.9b00518 |
| Homo sapiens |
Phosphodiesterase 4D |
IC50 |
540.0 |
nM |
10.1021/acs.jmedchem.0c00060 |
| Homo sapiens |
Phosphodiesterase 4D |
Imax |
99.0 |
% |
10.1021/acs.jmedchem.9b00193 |
| Homo sapiens |
Plasma |
PPB |
90.0 |
% |
10.1021/jm900210d |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
4500.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Sodium channel protein type V alpha subunit |
AC50 |
50000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
50000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1016/j.bmc.2021.116015 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b00518 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1021/jm900210d |
| Rattus norvegicus |
Rattus norvegicus |
AUC |
11000.0 |
ng.hr.mL-1 |
10.1021/jm900210d |
| Rattus norvegicus |
Rattus norvegicus |
AUC |
14000.0 |
ng.hr.mL-1 |
10.1021/jm900210d |
| Rattus norvegicus |
Rattus norvegicus |
CL |
8.333 |
mL.min-1.kg-1 |
10.1021/jm900210d |
| Rattus norvegicus |
Rattus norvegicus |
Cmax |
2388.66 |
nM |
10.1021/jm900210d |
| Rattus norvegicus |
Rattus norvegicus |
Cmax |
14331.94 |
nM |
10.1021/jm900210d |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
0.03 |
mg.kg-1 |
10.1021/jm900210d |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
0.3 |
mg.kg-1 |
10.1021/jm900210d |
| Rattus norvegicus |
Rattus norvegicus |
F |
64.0 |
% |
10.1021/jm900210d |
| Rattus norvegicus |
Rattus norvegicus |
T1/2 |
3.0 |
hr |
10.1021/jm900210d |
| Rattus norvegicus |
Rattus norvegicus |
T1/2 |
5.0 |
hr |
10.1021/jm900210d |
| Rattus norvegicus |
Rattus norvegicus |
Vdss |
2.0 |
L.kg-1 |
10.1021/jm900210d |
| Rattus norvegicus |
Synaptic vesicular amine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
-0.6639 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
13.15 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.2459 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.02 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.06 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
5.54 |
% |
10.21203/rs.3.rs-23951/v1 |
| None |
ADMET |
Activity |
nan |
None |
10.1016/j.bmc.2021.116015 |
| None |
ADMET |
Drug recovery |
92.12 |
% |
10.1021/acs.jmedchem.9b00518 |
| None |
ADMET |
Drug recovery |
96.68 |
% |
10.1021/acs.jmedchem.9b00518 |
| None |
ADMET |
Fabs |
100.0 |
% |
10.1021/acs.jmedchem.9b00518 |
| None |
ADMET |
Papp |
14.93 |
10'-6 cm/s |
10.1021/acs.jmedchem.9b00518 |
| None |
ADMET |
Papp |
29.02 |
10'-6 cm/s |
10.1021/acs.jmedchem.9b00518 |
| None |
ADMET |
Ratio |
1.9 |
None |
10.1021/acs.jmedchem.9b00518 |
| None |
ADMET |
T1/2 |
1.0 |
hr |
10.1021/jm900210d |
| None |
No relevant target |
pKa |
9.8 |
None |
10.1124/dmd.112.050278 |
| None |
Unchecked |
IC50 |
21.0 |
nM |
10.1021/acs.jmedchem.9b00193 |
| None |
Unchecked |
IC50 |
23.0 |
nM |
10.1021/acs.jmedchem.9b00193 |
| None |
Unchecked |
IC50 |
26.0 |
nM |
10.1021/acs.jmedchem.9b00193 |
| None |
Unchecked |
IC50 |
32.0 |
nM |
10.1021/acs.jmedchem.9b00193 |
| None |
Unchecked |
IC50 |
77.0 |
nM |
10.1016/j.bmc.2016.09.011 |
| None |
Unchecked |
Imax |
96.0 |
% |
10.1021/acs.jmedchem.9b00193 |
| None |
Unchecked |
Imax |
97.0 |
% |
10.1021/acs.jmedchem.9b00193 |
| None |
Unchecked |
Imax |
98.0 |
% |
10.1021/acs.jmedchem.9b00193 |
| None |
Unchecked |
Inhibition |
13.0 |
% |
10.1016/j.ejmech.2019.04.020 |
| None |
Unchecked |
Inhibition |
58.0 |
% |
10.1016/j.ejmech.2019.04.020 |
| None |
Unchecked |
Inhibition |
89.0 |
% |
10.1016/j.ejmech.2019.04.020 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.bmc.2016.09.011 |